Drug Profile


Alternative Names: Ambroxol HCl/levodropropizine; HCP1103; Levodropropizine/ambroxol; Levodropropizine/ambroxol HCl

Latest Information Update: 04 May 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Hanmi Pharmaceutical
  • Class Antitussives; Expectorants; Small molecules
  • Mechanism of Action Free radical scavengers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Cough

Most Recent Events

  • 04 May 2015 No development reported - Phase-I for Cough (In volunteers) in South Korea (PO)
  • 31 Dec 2011 Preclinical trials in Cough in South Korea (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top